Back
Plexus Corp. Vs. Novo Nordisk A/S Industry Stock Comparison
Buy
63
PLXS
Plexus Corp.
Last Price:
$154.03
Seasonality Move:
4.08%
Sell
36
NONOF
Novo Nordisk A/S
Last Price:
$48.82
Seasonality Move:
2.46%
Buy
63
Plexus Corp. (PLXS)
is a Buy
Is Plexus Corp. a Buy, Sell or Hold?
-
The current Plexus Corp. [PLXS] share price is $159.72. The Score for PLXS is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
-
PLXS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
36
Novo Nordisk A/S (NONOF)
is a Sell
Is Novo Nordisk A/S a Buy, Sell or Hold?
-
The current Novo Nordisk A/S [NONOF] share price is $50.35. The Score for NONOF is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
-
NONOF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PLXS Stock Price Chart
What is Plexus Corp.'s stock price today?
-
The Plexus Corp. share price today is $159.72The current trend is moderately bullish and PLXS is experiencing selling pressure, which indicates risk of future bearish movement.
NONOF Stock Price Chart
What is Novo Nordisk A/S's stock price today?
-
The Novo Nordisk A/S share price today is $50.35The current trend is relatively stagnant and NONOF is experiencing buying pressure, which is a positive indicator for future bullish movement.
PLXS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.07 | Buy |
| Relative Strength Index (14 RSI): | 63.64 | Buy |
| Chaikin Money Flow: | -113713 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (137.76 - 155.22) | Buy |
| Bollinger Bands (100): | (132.42 - 148.86) | Buy |
NONOF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.21 | Sell |
| Relative Strength Index (14 RSI): | 55.15 | Buy |
| Chaikin Money Flow: | 25503 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.69 - 49.19) | Buy |
| Bollinger Bands (100): | (48.01 - 58.07) | Sell |
PLXS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 157.22 | Buy |
| 20-day SMA: | 147.31 | Buy |
| 50-day SMA: | 145.5 | Buy |
| 200-day SMA: | 134.82 | Buy |
| 8-day EMA: | 157.31 | Buy |
| 20-day EMA: | 151.1 | Buy |
| 50-day EMA: | 146.14 | Buy |
| 200-day EMA: | 138.74 | Buy |
NONOF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 48.46 | Buy |
| 20-day SMA: | 47.82 | Buy |
| 50-day SMA: | 50.95 | Sell |
| 200-day SMA: | 61.56 | Sell |
| 8-day EMA: | 48.93 | Buy |
| 20-day EMA: | 48.57 | Buy |
| 50-day EMA: | 50.49 | Sell |
| 200-day EMA: | 63.61 | Sell |
Plexus Corp. Earnings Growth & PLXS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.72 per share, and an increase next year of $0.22 per share.
Novo Nordisk A/S Earnings Growth & NONOF Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and a decrease next year of $0.00 per share.
Plexus Corp. Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Novo Nordisk A/S Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||